col blocks we are bridge builder col blocks
COVID answers in Scientific Journals all over the world

309 Results       Page 1

Elsevier: Diabetes Research and Clinical Practice
  original article Date Title Authors   All Authors
1 [GO] 2024―Mar―28 IDF23-0076 Impact of diabetes mellitus on Liver Transaminases (SGPT & SGOT levels) in patients affected with COVID-19 A. Inamdar
2 [GO] 2024―Mar―28 IDF23-0027 The Role of Parental Mental Health in the Mental Health of Children with Type 1 Diabetes During COVID-19 J. Daly
3 [GO] 2024―Mar―28 IDF23-0489 Polymorphic variants of the TCF7L2 gene in patients with Covid-19, diabetes mellitus type 2 and fatty liver disease I. Darashkevich, T.V. Mokhort, M. Kurbat
4 [GO] 2024―Mar―28 IDF23-0547 COVID-19 disruption on diabetic retinopathy screening coverage under AI implementation: A descriptive analysis R. Silva-jorquera
5 [GO] 2024―Mar―28 IDF23-0569 Role of medical professional societies in response to the COVID-19 global pandemic in Jordan R. Kahale, M. Barham, S. Jaffal, E. Barham, N. Shegem
6 [GO] 2024―Mar―28 IDF23-0125 Study of renal impairment in diabetic patients affected with COVID-19 in rural India A. Inamdar
7 [GO] 2024―Mar―28 IDF23-0102 A meta-analysis on the association of gestational diabetes mellitus with COVID-19 infection V. Shivam, V. Senathipathi, P. Vinayagam
8 [GO] 2024―Mar―28 IDF23-0112 Gestational diabetes as a risk factor for COVID-19 infection: A meta-analysis V. Shivam, P. Vinayagam, V. Senathipathi
9 [GO] 2024―Mar―28 IDF23-0483 Estimation of Triglycerides and Glucose Index in Patients after COVID-19 Infection: A Population-based Study F. Nildibayeva, D. Sheryazdanova, V. Parakhina, N. Zhanbasinova, A. Turmukhambetova
10 [GO] 2024―Mar―28 IDF23-0033 Association of Diabetes with COVID-19 Mortality: A Systematic Review and Meta-Analysis of 118 Observational Studies C. Li, N. Islam, J.P. Gutiérrez, S.E. Gutiérrez-Barreto, A.C. Prado, R.L. Moolenaar, et al. (+2)
11 [GO] 2024―Mar―28 IDF23-0197 The Impact of COVID-19 on Diabetes Management System in LMICs: A Systematic Review and the Way Forward M. Chen, H. Ougui
12 [GO] 2024―Mar―28 IDF23-0528 Participation in a long-lasting community-based diabetes prevention program during the COVID-19 pandemic K. Cybulska, B. Piwońska-Solska, A. Gilis-Januszewska, A. Hubalewska-Dydejczyk
13 [GO] 2024―Mar―28 IDF23-0511 Increased urban prevalence of diabetes in Colombia after the COVID-19 pandemic C.O. Mendivil Anaya, A. Pérez-Londoño, V. Cuellar-Rodríguez, I. Correa-Osio, C. Betancourt-Villamizar
14 [GO] 2024―Mar―28 IDF23-0492 Engagement with diabetic screening services in patients admitted with DKA pre-, post and during the COVID-19 pandemic I. Georganta, S. MacKenzie, A. Lockman, T. Chambers
15 [GO] 2024―Mar―28 IDF23-0101 Ameta-analysis on the prevalence of gestational diabetes mellitus during COVID-19 pandemic and pre-pandemic period V. Shivam, P. Vinayagam, V. Senathipathi, S. Murugesan
16 [GO] 2024―Mar―28 IDF23-0527 Modification of diabetes prevention program during the COVID-19 pandemic, identification of the implementation barriers K. Cybulska, B. Piwońska-Solska, A. Gilis-Januszewska, A. Hubalewska-Dydejczyk
17 [GO] 2024―Mar―28 IDF23-0399 Major and Minor Amputation during Covid-19 Pandemic in a Tertiary Care Hospital A. Bal, R. Rontgen, A. Bhoraskar
18 [GO] 2024―Mar―28 IDF23-0091 Impact of COVID-19 pandemic on dyslipidemia and hypertension in patients with type 2 diabetes mellitus P. Vinayagam, V. Shivam, V. Senathipathi
19 [GO] 2024―Mar―28 IDF23-0375 Self-management barriers of diabetic patients during the COVID-19 quarantine period in Vlore, Albania M. Zahaj, S. Likaj, E. Kiçaj
20 [GO] 2024―Mar―28 IDF23-0240 Association of COVID-19 with new-onset diabetes in a geographically and ethnically diverse cohort of US adults S. Patel, B. McDonald, C. Hu, C. Wong, T. Kimes, M. Crawford, et al. (+5)
21 [GO] 2024―Mar―28 IDF23-0099 Diabetes and COVID-19: a two-way relationship M. Ghazali, M.L. Djama, H. Bacha, M. Boucelma
22 [GO] 2024―Mar―28 IDF23-0507 Effect of mySugr App on Self-Management in Type 2 Diabetes during the Transition out of Pandemic: A Prospective Study M.H. Gomez, N.A. Luna, D.Y. Bawal, M.K. Caro
23 [GO] 2024―Mar―28 IDF23-0557 Long Covid in People with Type 2 Diabetes: Preliminary Results J.M. Gutierrez-valverde
24 [GO] 2024―Feb―02 The COVID-19 pandemic and its impact on the development of gestational diabetes mellitus (GDM) in West Virginia Jana Garrow, Isadora Fan, Christa Lilly, Candice Lefeber, Bethany Barone Gibbs, Timothy Lefeber, et al. (+2)
25 [GO] 2023―Dec―16 Pediatric Diabetes Mellitus Hospitalizations and COVID-19 Pandemic Response Measures Hope Shimony, Lauren Miller, Patrick Reich, Nicholas R. Banull, Maureen Burch, Melanie Bryan, Ana María Arbeláez
26 [GO] 2023―Dec―09 Glucose Control During Breakthrough SARS-CoV-2 Infections in Vaccinated Patients With Type 1 Diabetes Miriam Longo, Lorenzo Scappaticcio, Simona Signoriello, Paola Caruso, Antonietta Maio, Graziella Botta, et al. (+7)
27 [GO] 2023―Nov―26 Interpreting with caution of the higher occurrence of pediatric new-onset type 1 diabetes during the COVID-19 pandemic Ying Cai, Yan Fang Zhang, Shu Qi Wu, Cai Yun Xia, Qian Yang, Dao Ting Li, et al. (+2)
28 [GO] 2023―Nov―24 Quantitative Sensory Testing Defines the Trajectory of Sensory Neuropathy after Severe COVID-19 Georgios Ponirakis, Ariel Odriozola, Lucía Ortega, Lidia Martinez, Samantha Odriozola, Ainhoa Torrens, et al. (+9)
29 [GO] 2023―Oct―29 Change in testing for blood glucose during the COVID-19 pandemic, United States 2019-2021 Yoshihisa Miyamoto, Ryan Saelee, Alain K. Koyama, Ibrahim Zaganjor, Fang Xu, Stephen Onufrak, Meda E. Pavkov
30 [GO] 2023―Oct―25 Paediatric New Onset Type 1 Diabetes and Diabetic Ketoacidosis during the COVID-19 Pandemic in Malaysia Yee Lin Lee, Fatin Farihah Wan Ahmad Nasir, Nalini M Selveindran, Azriyanti Anuar Zaini, Poi Giok Lim, Muhammad Yazid Jalaludin
31 [GO] 2023―Sep―09 Effects of the COVID-19 Booster Vaccine on Glycemia and Insulin Resistance in People with Type 1 Diabetes: A Prospective Pilot Study Mihail Zilbermint, Mahsa Motevalli, Kristine Batty, Jemila Venner-Walcott, Alexis Edwards, Tanya Burley, et al. (+3)
32 [GO] 2023―Sep―06 Type 2 diabetes and Covid-19: Lessons learnt, unanswered questions and hints for the future Parsa Nazari, Paolo Pozzilli
33 [GO] 2023―Jun―27 Diabetes care practices and outcomes in 40.000 children and adolescents with type 1 diabetes from the SWEET registry during the COVID-19 pandemic Agata Chobot, Stefanie Lanzinger, Hessa Alkandari, G. Todd Alonso, Nicole Blauensteiner, Nicole Coles, et al. (+7)
34 [GO] 2023―May―24 Global acceptance of COVID-19 vaccine among persons with diabetes: A systematic review and meta-analysis Emmanuel Ekpor, Samuel Akyirem
35 [GO] 2023―May―18 Association between Covid-19 vaccination and incidence of Type 1 diabetes in China: evidence from 14.14 million registered residents between 2007 and 2021 Chang Liu, Mo-Ning Guo, Zhonglin Chai, Zhong Xin, Guanjie Chen, Paul Z Zimmet, Jin-Kui Yang
36 [GO] 2023―May―08 The effectiveness of COVID-19 vaccination against all-cause mortality in patients with type 2 diabetes mellitus: the observation during the initial period of the cancellation of the “Dynamic Zero Policy” in mainland China Shijun Liu, Caixia Jiang, Yan Liu, Yan Zhang, Xin Qiu, Jun Luo, et al. (+2)
37 [GO] 2023―May―06 Metformin use before COVID-19 vaccination and the risks of COVID-19 incidence, medical utilization, and all-cause mortality in patients with type 2 diabetes mellitus Fu-Shun Yen, Shiow-Ing Wang, Shih-Yi Lin, James Cheng-Chung Wei
38 [GO] 2023―Apr―02 Repurposing exercise training and pharmacological therapies to address the post-acute sequelae of COVID-19 (PASC) in Diabetes Mellitus Ying Jie Chee, Rinkoo Dalan
39 [GO] 2023―Mar―15 IDF2022-0622 Mortality and cardiorenal disease in type 1 and type 2 diabetes after COVID-19 and influenza hospitalization in Sweden R. Kristófl, J. Bodegard, V. Ritsinger, M. Thuresson, D. Nathanson, T. Nyström, et al. (+2)
40 [GO] 2023―Mar―15 IDF2022-1332 COVID-19 and type I diabetes prevalence among children in Georgian children population K. Amirkhanashvili, N. Bikashvili, T. Kukhaleishvili, M. Kuparashvili
41 [GO] 2023―Mar―15 IDF2022-0579 Post COVID-19 diabetes project: Intensive cardio-renal-metabolic management for people living with type 2 diabetes (T2D) E. Ahmad, V. Alabraba, M. Skarlatos, M.M. Barker, H. Trivedi, L. Herring, et al. (+3)
42 [GO] 2023―Mar―15 IDF2022-0830 Clinical Characteristics of Autoantibody-Negative Type 1 Diabetes Onset in Children During the COVID-19 Era in Kuwait F. Othman, D. Al-Abdulrazzaq, F. Al-Juailla, H. Al-Kandari
43 [GO] 2023―Mar―15 IDF2022-0635 Can COVID-19 infection provoke new-onset A-β+ KPD (ketosis-prone diabetes)? - Insights from an Indian prospective study R. Dasgupta, S. Mondal, R. Garai, B. Chowdhury, A. Hazra, M. Lodh, A. Ganguly
44 [GO] 2023―Mar―15 IDF2022-0354 The impact of COVID-19 lockdown on the changes in glycated hemoglobin in patients with type 2 diabetic in Taiwan Y.C. Cheng
45 [GO] 2023―Mar―15 IDF2022-1150 The effect of COVID-19 on the management of diabetes in patients in Federally Qualified Health Centers in Puerto Rico M.D.M. González-Montalvo, S. Hassan
46 [GO] 2023―Mar―15 IDF2022-1189 Glucose control in men and women with diabetes before and during the COVID-19 pandemic J. Harding, B. McDonald, J. Gander, M. Ali
47 [GO] 2023―Mar―15 IDF2022-0928 Impact of the COVID-19 Pandemic on Type 2 Diabetes Incidence in Canada: Will the Pandemic shift the Diabetes Trajectory? G. Fazli, R. Moineddin, V. Ling, G. Booth
48 [GO] 2023―Mar―15 IDF2022-0337 Maternal and Neonatal Morbidity and Mortality Among COVID-19 positive Pregnant Women with and Without GDM M. Aljumah, M. Abufarha, H. Alyassen, T. Alessa, S. Devarajan, M. Nabil
49 [GO] 2023―Mar―15 IDF2022-0948 Health Inequality and its link to HbA1c Test Recovery in a Developed Health Economy: In a ‘Nearly Post COVID-19’ World A. Fryer, D. Holland, J. Scargill, C. Duff, F. Hanna, A. Heald
50 [GO] 2023―Mar―15 IDF2022-1158 Transition in Diabetes Mellitus Management Among Palestine Refugees During COVID-19; UNRWA’s Jordan Experience K. Naqera, M. Mahmoud Hamdi, R. Naqa, M. Ammoura, Y. Shahin, S. Attalah
51 [GO] 2023―Mar―15 IDF2022-0286 Presence of SARS-CoV-2 antibodies in asymptomatic type 1 diabetes; is there any association between glycemic control A. Fawwad, B. Tahir, R. Naseem, B. Malik, I.A. Siddiqui, A. Basit
52 [GO] 2023―Mar―15 IDF2022-0470 Health Literacy in Diabetes at pandemic time - Remote educational and motivational program for type 2 diabetes patients D.M.N. do Ó, C. Rodrigues, M.J. Sequeira, M. Pires, R. Cravinho, R. Andrade, et al. (+6)
53 [GO] 2023―Feb―23 Diabetes and Covid-19: Diabetes research funding and support during the pandemic SA. Hills, K Meadows, AM Felton, CJ Delicata, AJM Boulton
54 [GO] 2023―Feb―08 Incidence and presentation of new-onset type 1 diabetes in children and adolescents from Germany during the Covid-19 pandemic 2020 and 2021: current data from the DPV Registry C. Baechle, A. Eckert, C. Kamrath, A. Neu, U. Manuwald, S. Thiele-Schmitz, et al. (+4)
55 [GO] 2023―Feb―01 Extracellular vesicle proteomics and phosphoproteomics identify pathways for increased risk in patients hospitalized with COVID-19 and type 2 diabetes mellitus Yury O. Nunez Lopez, Anton Iliuk, Anna Casu, Amay Parikh, Joshua S. Smith, Karen Corbin, et al. (+2)
56 [GO] 2022―Dec―09 Pre-admission use of sodium glucose transporter-2 inhibitor (SGLT-2i) may significantly improves Covid-19 outcomes in patients with diabetes: A systematic review, meta-analysis, and meta-regression Hikmat Permana, Theo Audi Yanto, Timotius Ivan Hariyanto
57 [GO] 2022―Nov―28 Exploratory study on glycemic control improvement for patients with diabetes mellitus by appropriate re-education on insulin self-injection technique during COVID-19 pandemic Sachiko Honjo, Yukako Koshii, Shusaku Tozaka, Hiroko Tateno, Yamato Keidai, Yohei Seno, et al. (+4)
58 [GO] 2022―Nov―15 Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes Lauren E. Chan, Elena Casiraghi, Bryan Laraway, Ben Coleman, Hannah Blau, Adnin Zaman, et al. (+10)
59 [GO] 2022―Nov―15 Role of telemedicine during COVID-19 pandemic in type 2 diabetes outpatients: the AMD Annals Initiative Giuseppina T. Russo, Francesco Andreozzi, Mariella Calabrese, Paolo Di Bartolo, Graziano Di Cianni, Carlo Bruno Giorda, et al. (+10)
60 [GO] 2022―Nov―15 Impact of diabetes status and related factors on COVID-19-associated hospitalization: A nationwide retrospective cohort study of 116,370 adults with SARS-CoV-2 infection Erin M. Tallon, Osagie Ebekozien, Janine Sanchez, Vincent S. Staggs, Diana Ferro, Ryan McDonough, et al. (+11)
61 [GO] 2022―Nov―11 Dexamethasone-induced hyperglycaemia in COVID-19: Glycaemic profile in patients without diabetes and factors associated with hyperglycaemia Yoon Ji J Rhou, Amanda Hor, Mawson Wang, Yu-Fang Wu, Suja Jose, David R Chipps, Ngai Wah Cheung
62 [GO] 2022―Nov―05 Type 1 diabetes incidence in children and adolescents during the COVID-19 pandemic in Germany Louisa van den Boom, Karel Kostev, Oliver Kuss, Wolfgang Rathmann, Joachim Rosenbauer
63 [GO] 2022―Oct―28 Monthly video consultation for children and adolescents with type 1 diabetes mellitus during the COVID-19 pandemic Simone von Sengbusch, Julia Schneidewind, Jessica Bokelmann, Nadine Scheffler, Bettina Bertram, Fabian-Simon Frielitz, et al. (+2)
64 [GO] 2022―Aug―28 Does diabetes risk after SARS-CoV-2 infection depend on the viral variant? Rohita Rangu, Pandora L. Wander, Sakeneh Zraika
65 [GO] 2022―Aug―27 Diabetes and COVID-19 testing, positivity, and mortality: A population-wide study in Northern Italy Olivera Djuric, Marta Ottone, Massimo Vicentini, Francesco Venturelli, Annamaria Pezzarossi, Valeria Manicardi, et al. (+2)
66 [GO] 2022―Aug―06 COVID-19 Induced Diabetes: A Novel Presentation Samruddhi Chandrashekhar Joshi, Paolo Pozzilli
67 [GO] 2022―Jul―27 Diabetes Research and Clinical Practice and the fight against COVID-19 Antonio Ceriello
68 [GO] 2022―Jul―07 Stress hyperglycemia ratio, rather than admission blood glucose, predicts in-hospital mortality and adverse outcomes in moderate-to severe COVID-19 patients, irrespective of pre-existing glycemic status Sunetra Mondal, Riddhi DasGupta, Moushumi Lodh, Ramprasad Garai, Brojen Choudhury, Arindam Kumar Hazra, et al. (+2)
69 [GO] 2022―Jul―06 Diabetes as a cause of death across different COVID-19 epidemic waves Ugo Fedeli, Veronica Casotto, Elena Schievano, Enzo Bonora, Giacomo Zoppini
70 [GO] 2022―Jun―14 Determinants of COVID-19 vaccine acceptance among adults with diabetes and in the general population in Israel: A cross-sectional study Tatyana Kolobov, Simcha Djuraev, Sara Promislow, Orly Tamir
71 [GO] 2022―Jun―03 IDF21-0472 The effect of structured diabetes self-management education care on glycaemic control in Accra subsequent to COVID-19 R. Lamptey, M. Amoakoh-Coleman, K. Klipstein-Grobusch, D. Darko, I.A. Agyepong, F. Acheampong, et al. (+6)
72 [GO] 2022―Jun―03 IDF21-0663 Health-Related Quality of Life in Moroccan patients with diabetes after hospitalization for COVID-19 A. Azizi, D. Achak, I. Youlyouz-Marfak, E. Saad, A. Hilali, A. Marfak
73 [GO] 2022―Jun―03 IDF21-0521 Peer Support for Diabetes Management in the Shanghai Integration Model Developed Community Capacity to Combat COVID-19 Y. Liu, P. Tang, M. Evans, Y. Qian, X. Wu, C. Cai, et al. (+3)
74 [GO] 2022―Jun―03 IDF21-0392 Association of sleep quality with depression, anxiety and stress symptoms in Indian adults with diabetes during COVID-19 P. Moitra, J. Kalgi, S. Shah, J. Madan
75 [GO] 2022―Jun―03 IDF21-0411 Correlation of Chest CT severity score with blood glucose levels in patients with COVID-19 A. Inamdar, B. Saboo
76 [GO] 2022―Jun―03 IDF21-0377 Evaluation of the glycemic profile during 6 months after hospital discharge of patients with severe COVID-19 M. Lima, I. Moulaz, J. Polese, J.G. Mill, M. Pazolini
77 [GO] 2022―Jun―03 IDF21-0311 Pre-Admission, Diabetic Glycemic Control on 60-Day Mortality and Major Adverse Cardiovascular Events from COVID-19 M. Ruge, U. Sriram, J.M.D. Gomez, J. Du Fay De Lavallaz, E. Gajo, A. Sarau, et al. (+3)
78 [GO] 2022―Jun―03 IDF21-0230 Anti-inflammatory activity of glyoxalase-1 inducer supports further evaluation for prevention of COVID-19 M. Xue, N. Rabbani, P. Thornalley
79 [GO] 2022―Jun―03 IDF21-0110 The role of source hypoglycemic therapy and associated diseases in patients with type 2 diabetes mellitus and COVID-19 T.N. Markova, A.A. Ponomareva
80 [GO] 2022―Jun―03 IDF21-0109 Coagulation Disorders in Type 2 Diabetes Mellitus Patients with COVID-19 C. Syukur, Y.A. Langi, B. Sedli, K. Pandelaki
81 [GO] 2022―Jun―03 IDF21-0214 COVID-19 & Diabetes in Canada: Two Global Pandemics Colliding & An Opportunity For Optimizing Data-Driven Diabetes Care Delivery & Outcomes in British Columbia (BC) W. Leong, M. Pennock, K. Reimer, J. Sutherland
82 [GO] 2022―Jun―03 IDF21-0363 Evaluation of virtual consultation and patient satisfaction during COVID-19 - Survey at the Chronic Care Center, Lebanon C. Rayes Sadek, T. Abou Nasr, C. Bitar, M. Abi Saad
83 [GO] 2022―Jun―03 IDF21-0273 New-Onset Diabetic Ketoacidosis as a first manifestation of Covid-19 at emergency department R. Dhokar, H. Ghazali, I. Chermiti, H. Ben Abessia, A. Ben Garfa, S. Keskes, et al. (+2)
84 [GO] 2022―Jun―03 IDF21-0444 Association Between Prior Antidiabetic Therapy and Outcome in Hospitalized COVID-19 Diabetic Subjects A. Baidya, R. Ahmed
85 [GO] 2022―Jun―03 IDF21-0211 Relationship between COVID-19 disrupted lifestyle habits and mental health in Canadian adults with type 1 diabetes T. Tang, A. Vesco, E. Fraser
86 [GO] 2022―Jun―03 IDF21-0489 Effect of COVID-19 disruption on Clinical study of Patients with Diabetic Macular Oedema Who Wore a Home-Use Sleep Mask D. Hill, I. Grierson, M. Hopkins, A. Farrar, U. Meyer-bothling
87 [GO] 2022―Jun―03 IDF21-0194 Impact of COVID-19 during period of Level 3 alert on access to diabetes care in central Taiwan Y.S. Yang, C.N. Huang, E. Kornelius, L. Shih-chang
88 [GO] 2022―Jun―03 IDF21-0190 Maternal and perinatal outcomes during the COVID-19 epidemic in pregnancies complicated by gestational diabetes A. Munda, B. Šturm, G. Okanovič, K. Zorko, L. Steblovnik, D. Pongrac Barlovic
89 [GO] 2022―Jun―03 IDF21-0168 Pathway to Clinical Diabetes Services in COVID-19 Era: What Has Changed and What Are the Implications? E. Adwubi, J. Nonvignon, R. Van Der Meer, I. Megiddo, B. Godman
90 [GO] 2022―Jun―03 IDF21-0593 COVID-19 hospitalizations and cardio-cerebrovascular complications at three months in people with diabetes M. Iommi, C. Reno, J. Lenzi, R. Messina, M. Altini, F. Bravi, et al. (+2)
91 [GO] 2022―Jun―03 IDF21-0275 Association between hyperglycemia treatment and mortality in patients with diabetes and COVID-19 in a Peruvian hospital E. Lopez-Huamanrayme, D.D. Garate-Chirinos, F. Espinoza-Morales, F. Pasquel
92 [GO] 2022―Jun―03 IDF21-0416 Mortality risk factors due to COVID-19 in diabetic patients according to the nationwide diabetes register analysis M. Shestakova, O. Vikulova, A. Ajnetdinova, I. Dedov, N. Mokrysheva
93 [GO] 2022―Jun―03 IDF21-0532 Hyponatremia severity affects patient outcome in COVID-19 infection J. Bogdanovic, I. Babic, T. Adzic Vukicevic, K. Lalic, D. Popovic, N. Lalic
94 [GO] 2022―Jun―03 IDF21-0524 Inhospital sodium variability associated with poor outcome in COVID-19 infection I. Babic, J. Bogdanovic, T. Adzic Vukicevic, K. Lalic, D. Popovic, N. Lalic
95 [GO] 2022―Jun―03 IDF21-0097 Concomitant COVID-19 Infection and Ketosis Prone Diabetes. Coincidence or Relationship? A Case Report L. Gonzalez, D. Muñoz, R.J. Añez, A.M. Rivas, A. García, I. Losada, et al. (+5)
96 [GO] 2022―Jun―03 IDF21-0574 Type 1 Diabetes onset and COVID-19 infection in a child with Sanjad Sakati Syndrome: a case from Kuwait F. Othman, K. Al-kandari, F. Mandani, Z. Al-mazidi, D. Al-abdulrazzaq, H. Al-kandari
97 [GO] 2022―Jun―03 IDF21-0542 Sharing “” Experiences of how the Institution Have Faced COVID-19 Issues H.A. Ramamonjisoa, T. Rajaonarison, C. Rakotonirina, J. Ratsitratrinihafa, M. Rakotoarimanana, J.P. Assal, G. Ramahandridona
98 [GO] 2022―Jun―03 IDF21-0450 Effect of COVID-19 lockdown and Ramadan fasting on glucose control in patients with diabetes: a glucose monitoring study R. Helal, T. Ashraf, M. Majeed, N. Lessan
99 [GO] 2022―Jun―03 IDF21-0636 Effects of COVID-19 lockdown on lifestyle changes and medical challenges in patients with type 1 diabetes in south India R.P. Guha Pradeepa, R.M. Anjana, A. Amutha, C.S. Shanthi Rani, S. Jebarani, U. Venkatesan, et al. (+2)
100 [GO] 2022―Jun―03 IDF21-0274 Impact of COVID-19 on Glycemic control in children with T1D in Kuwait F. Aljuailla, T. Alqaisi, F. Othman, D. Khalifa, A. Alkandari, D. Al-abdulrazzaq, H. Alkandari
101 [GO] 2022―Jun―03 IDF21-0160 Impact of COVID-19 on Health-Related Quality of Life and Glycemic Status of Type 1 Diabetes Children in Kuwait T. Alqaisi, F. Aljuailla, F. Othman, D. Khalifa, A. Alkandari, H. Alkandari, D. Alabdulrazzaq
102 [GO] 2022―Jun―03 IDF21-0090 Structure of mortality among patients with diabetes mellitus in the republic of Uzbekistan during COVID-19 pandemia I. Tojieva, A. Alieva, K. Feruza, D. Berdikulova, N. Alimova
103 [GO] 2022―Jun―03 IDF21-0175 Experiences of delivering virtual education workshops for children with type 1 diabetes during the Covid-19 pandemic P.L.C. Chan, Y.L. Tung Joanna, Y.M. Poon Iris, S.W. Pang Gloria, L.K. Lee Samantha, A.N. Tang Christine
104 [GO] 2022―Jun―03 IDF21-0678 Telemedicine Use and Selfmanagement Behaviors of Persons with Type 2 DM in Luzon Philippines during the COVID-19 Pandemic M. Abaigar Jr., A. Bautistav
105 [GO] 2022―Jun―03 IDF21-0564 The Use of a Digital Self-Care Platform in The Control of Diabetes in People With Diabetes During the COVID-19 Pandemic M. Jacobs, A. Ogboye, K.M.J. Rahman, J. Akpakli, L. Tian, L.N. Mobisson, K. Njoku
106 [GO] 2022―Jun―03 IDF21-0373 Online education for parents of children and adolescents with newly diagnosed type 1 diabetes during COVID-19 pandemic A. Kurganovich, A. Mayorov, A. Karpushkina
107 [GO] 2022―Jun―03 IDF21-0452 Virtual Diabetes Education Program for Children and Adolescents with Diabetes in Response to COVID-19 Pandemic D. Alromaihi, S. Al-Qattan, M. Alhajeri, F. Rajab, R. Ebrahim, E. Aljahmi
108 [GO] 2022―Jun―03 IDF21-0370 New forms of diabetic education during the COVID-19 pandemic A. Bukovská
109 [GO] 2022―Jun―03 IDF21-0340 Challenges Faced by Patients in Diabetes Care and Management in the Philippines During the COVID-19 Pandemic C.J. Quinto, J.M. Pamittan, C.A. Paraguison, M.J. Peralta, H.M. Perdido
110 [GO] 2022―Jun―03 IDF21-0295 Cost-effectiveness of telemedicine care for uncontrolled type 2 diabetes mellitus patients during the COVID-19 pandemic M. Almutairi, M.A. Bin Rsheed, J.T. Alharbi, M.A. Tourkmani, A.A Alrasheedy, Y. Alruthia, M. Aljehani
111 [GO] 2022―Jun―03 IDF21-0099 Development of self-management program with carbohydrate counting for Type 1 Diabetes delivered during Covid-19 pandemic L. Gupta, P. Rishi Lal
112 [GO] 2022―Jun―03 IDF21-0499 How has the COVID-19 pandemic affected psychosocial health in people with diabetes? A one-year follow-up study K. Olesen, I. Willaing, K.P. Madsen, L. Eide Joensen
113 [GO] 2022―Jun―03 IDF21-0611 The COVID-19 pandemic and Type 1 Diabetes (T1D): effect of the second wave on newly diagnosed children with T1D F. Othman, F. Al-juailla, T. Al-qaisi, A. Al-kandari, D. Al-abdulrazzaq, H. Al-kandari
114 [GO] 2022―Jun―03 IDF21-0257 The Feasibility of a Social Media-based Diabetic Foot Ulcer Prevention Program during the COVID-19 Pandemic in Canada H. Obilor, K. Woo
115 [GO] 2022―Jun―03 IDF21-0186 Real-world effectiveness of Diabefly digital therapeutics program for glycemic control during COVID-19 pandemic in India R. Verma, R. Ranadive, S. Kalra, T. Lathia, A. Saraf, S. Thakur, et al. (+6)
116 [GO] 2022―Jun―03 IDF21-0683 Social and emotional impact of the COVID-19 pandemic in people with Type 1 Diabetes B.F. Rodriguez Montalvan, V. Alcantara Aragon, M. Piedra Leon, J.A. Artal Simon, H.C. Sara, L.M. Gaite Pindado, et al. (+6)
117 [GO] 2022―Jun―03 IDF21-0294 Impact of COVID-19 pandemic lockdown in Spain on metabolic control of patients with type 2 diabetes mellitus G. Cornadó-Cubells, J.J. Cabré
118 [GO] 2022―Jun―03 IDF21-0470 Neither plasma glucose at admission nor in-hospital hyperglycaemia predict poor clinical outcomes in COVID-19 patients P. Sharma, R. Pal, V. Dhiman, S.K. Bhadada, K. S, M.P. Singh, et al. (+6)
119 [GO] 2022―Jun―03 IDF21-0439 Type 2 Diabetes Mellitus History in the Prognosis of Hospitalized COVID-19 Patients - A Prospective Observational Study J.J. Kochuparambil, A. Issac
120 [GO] 2022―Jun―03 IDF21-0533 Diabetes Mellitus in hospitalized COVID-19 patients - a retrospective cohort study A. Çerma, A. Haxhiraj, A. Muja, D. Ylli
121 [GO] 2022―Jun―03 IDF21-0567 Analysis of mortality and cardio-metabolic comorbidities in Covid-19 patients from Eastern European region I. Popescu, C. Bumgardner, D. Iancu, G.M. Mussman, C.B. Hughes, J.L. Fowlkes, C. Preda
122 [GO] 2022―Jun―03 IDF21-0631 Evaluating the significance of elevated HbA1c readings in COVID-19 patients treated with Dexamethasone - a QI project S. Sajeev, B. Jajah
123 [GO] 2022―Jun―03 IDF21-0320 Mortality and severity among Covid-19 patients who already vaccinated with inactivated Covid-19 vaccine D.V. Tanod, A. Abdurrahmanto
124 [GO] 2022―Jun―03 IDF21-0421 High blood sugar as a risk factor for post COVID-19 rhino-orbital-cerebral mucormycosis S. Dubey, S. Yadalla, N. Prabu, A. Dubey, V. Ramakrishnan
125 [GO] 2022―Jun―03 IDF21-0539 Can the asymptomatic COVID-19 trigger the development of diabetes mellitus? L. Jashi, K. Dundua, R. Kvanchakhadze, T. Peshkova
126 [GO] 2022―Jun―03 IDF21-0080 Determinants of acceptability to COVID-19 vaccine among the general public and diabetes population in Israel T. Kolobov, O. Tamir
127 [GO] 2022―Jun―03 IDF21-0557 Factors affecting Covid-19 Vaccine Attitude: Results from People Living with Chronic Conditions in Ibadan, Nigeria L. Ojewale, R. Afolabi
128 [GO] 2022―Jun―03 IDF21-0220 Hypertension as a Prognostic Factor in the Prediction of Mortality in Patients with COVID-19: A Meta-Analysis J.R. Juangco, C. Pagdanganan, U.G. Paguio, M.A. Palaspas, N.R. Palmares, J.S. Panalondong, et al. (+7)
129 [GO] 2022―Jun―03 IDF21-0510 Human Serum Metabolites as Potential Mediators from Obesity to COVID-19: A Network Mendelian Randomization Study C. Huang, M. Shi, J. Chan, R. Ma
130 [GO] 2022―Jun―03 IDF21-0123 Impact of Pre-existing Oral Antidiabetic Treatment on Clinical Outcomes of COVID-19: a Retrospective Study A. Navale, V. Devangan, A. Goswami, V. Sahu
131 [GO] 2022―Jun―03 IDF21-0583 Eye and COVID-19: A Systematic Literature Review and Bibliometric Analysis A. Forouhari, H. Ahmadieh, S. Safi, A. Ghaffari Jolfayi, V. Mansouri
132 [GO] 2022―Jun―03 IDF21-0301 Bridging the Needs of Adolescent Diabetes Care during Coronavirus Disease 2019: A Nurse-Led Telehealth Initiative S.T. Lim
133 [GO] 2022―Jun―03 IDF21-0272 Glycemic Variability in patients with SARS-CoV-2 admitted to the ICU N. Capellan, J. Echavarria, A. Sanchez, K. Disla, D. Mejia
134 [GO] 2022―Jun―03 IDF21-0367 Descriptive study of infection by SARS-COV-2 in adults with Diabetes Mellitus M.P. Russo, A.C. Murujosa, S.A. Giuliani Quaglieri, M.A. Risso, J.A. Pollan, M.F. Grande Ratti, et al. (+2)
135 [GO] 2022―Jun―03 IDF21-0463 Type 1 Diabetes with insulin resistance following SARS-CoV-2 infection D. Veríssimo, M. Borges, J. Galhardo, L. Lopes
136 [GO] 2022―Jun―03 IDF21-0512 Development of Latent Autoimmune Diabetes of Adults Post SARS-COV-2 mRNA Vaccination A. Kanzy, M. Madkhali, S. Imam, J. Jaume
137 [GO] 2022―Jun―03 IDF21-0353 Covid19 toe, a late manifestation of mild SARS-CoV-2 with Diabetes R. Jain, V. Seshiah, N. Bhavatharini, R. Shoghli, R. Jain, S. Davey, et al. (+2)
138 [GO] 2022―Jun―03 IDF21-0498 Innovative ways to continue serving People with Type 1 Diabetes during Covid 19 pandemic M. Abi Saad, C. Rayes Sadek
139 [GO] 2022―Jun―03 IDF21-0331 Diabetes care to Palestine Refugees during COVID 19 pandemic Y. Shahin
140 [GO] 2022―Jun―03 IDF21-0288 Virtually Sugar Free: Overcoming Challenges of Managing Gestational Diabetes (GDM) during a Pandemic R. Khurana, J. Tong, A. Jain, S. Stafford, A. Singh, N. Severin, et al. (+4)
141 [GO] 2022―Jun―03 IDF21-0046 Higher rates of DKA and intensive care admission among children newly diagnosed with T1D during the COVID 19 pandemic D. Al-abdulrazzaq, A. Alkandari, F. Ahusaini, N. Alenazi, U. Gujral, V. Narayan, H. Al-kandari
142 [GO] 2022―Jun―03 IDF21-0445 Telehealth utilization in Diabetes Centre during COVID Pandemic in South-Western Sydney: An evolving model of care M. Manoharan, W. Vincent, A. Wang
143 [GO] 2022―Jun―03 IDF21-0390 Diabetes related hospital presentations to South-Western Sydney during COVID Pandemic: A retrospective analysis D. Namboodiri, S. Homyra, M. Subedi, E. Garcia, V. Wong, M. Manoharan
144 [GO] 2022―Jun―03 IDF21-0422 Two Anniversaries, Two Pandemics, Two Histories A. Dapice
145 [GO] 2022―Apr―26 Glucometabolic changes influence hospitalization and outcome in patients with COVID-19: An observational cohort study Clara L. Clausen, Christian Leo-Hansen, Daniel Faurholt-Jepsen, Rikke Krogh-Madsen, Christian Ritz, Ole Kirk, et al. (+4)
146 [GO] 2022―Apr―13 Effect of diabetes on short-term mortality and incidence of first hospitalizations for cardiovascular events after recovery from SARS-CoV-2 infection Francesco Profili, Giuseppe Seghieri, Paolo Francesconi
147 [GO] 2022―Apr―05 PRE-EXISTING DIABETIC RETINOPATHY AS A PROGNOSTIC FACTOR FOR COVID-19 OUTCOMES AMONGST PEOPLE WITH DIABETES: A SYSTEMATIC REVIEW Isabel Boden, Miguel O. Bernabeu, Baljean Dhillon, David A. Dorward, Ian MacCormick, Roly Megaw, Claire Tochel
148 [GO] 2022―Mar―15 Higher HbA1c was observed in young people with diabetes who fasted during COVID -19 pandemic lockdown of 2020 Ramadan in Bangladesh - A Post Ramadan survey Bedowra Zabeen, Bulbul Ahmed, Jebun Nahar, Samin Tayyeb, Nasreen Islam, Fauzia Mohsin, Kishwar Azad
149 [GO] 2022―Mar―03 Diabetes and COVID-19: The potential role of mTOR B. Pinchera, R. Scotto, A.R. Buonomo, E. Zappulo, F. Stagnaro, A. Gallicchio, et al. (+6)
150 [GO] 2022―Feb―11 Delivering evidence-based interventions for Type 1 diabetes in the virtual world - a review of UK practice during the SARS-CoV-2 pandemic A. Sathyanarayanan, T. Crabtree, P. Choudhary, J. Elliott, M.L. Evans, A. Lumb, E.G. Wilmot
151 [GO] 2022―Feb―05 A prospective study of the impact of glycaemic status on clinical outcomes and anti-SARS-CoV-2 antibody responses among patients with predominantly non-severe COVID-19 David Tak Wai Lui, Yan Kiu Li, Chi Ho Lee, Wing Sun Chow, Alan Chun Hong Lee, Anthony Raymond Tam, et al. (+9)
152 [GO] 2022―Feb―02 Prevalence and correlates of diabetes distress and depressive symptoms among individuals with type-2 diabetes mellitus during Ramadan fasting: A cross-sectional study in Bangladesh amid the COVID-19 Mst. Sadia Sultana, Md. Saiful Islam, Abu Sayeed, Marc N. Potenza, Md Tajuddin Sikder, Muhammad Aziz Rahman, Kamrun Nahar Koly
153 [GO] 2021―Dec―13 It’s time to tackle the growing diabetes pandemic Andrew Boulton
154 [GO] 2021―Nov―19 COVID-19 pandemic: impact on gestational diabetes mellitus prevalence Vincenzo Zanardo, Domenico Tortora, Andrea Sandri, Lorenzo Severino, Paolo Mesirca, Gianluca Straface
155 [GO] 2021―Nov―18 Diabetes is “a pandemic of unprecedented magnitude” now affecting one in 10 adults worldwide
156 [GO] 2021―Nov―09 Corrigendum to ‘A novel indicator predicts 2019 novel coronavirus infection in subjects with diabetes’. [Diab. Res. Clin. Practice 166 (2020) 108294] Aclan Ozder, Zeyneb Irem Yuksel Salduz, Bulent Durdu, Fatmanur Okyaltirik, Mustafa Cakirca
157 [GO] 2021―Nov―06 Association between the reduction of face-to-face appointments and the control of patients with type 2 diabetes mellitus during the Covid-19 pandemic in Catalonia Ermengol Coma, Queralt Miró, Manuel Medina, Francesc X. Marin-Gomez, Xavier Cos, Mència Benítez, et al. (+5)
158 [GO] 2021―Sep―23 Glycaemic control during the lockdown for COVID-19 in adults with type 1 diabetes: A meta-analysis of observational studies Monia Garofolo, Michele Aragona, Cosimo Rodia, Pierpaolo Falcetta, Alessandra Bertolotto, Fabrizio Campi, et al. (+2)
159 [GO] 2021―Sep―14 The experience of patients with diabetes with the use of telemedicine and teleassistance services during the COVID-19 pandemic in Italy: factors associated with perceived quality and willingness to continue Elisa Maietti, Francesco Sanmarchi, Luigi Palestini, Davide Golinelli, Francesco Esposito, Nunzia Boccaforno, et al. (+2)
160 [GO] 2021―Sep―06 Fasting plasma glucose and glucose fluctuation are associated with COVID-19 prognosis regardless of pre-existing diabetes Weijia Xie, Na Wu, Bin Wang, Yu Xu, Yao Zhang, Ying Xiang, et al. (+10)
161 [GO] 2021―Aug―28 Pre-admission glucagon-like peptide-1 receptor agonist (GLP-1RA) and mortality from coronavirus disease 2019 (Covid-19): A systematic review, meta-analysis, and meta-regression Timotius Ivan Hariyanto, Denny Intan, Joshua Edward Hananto, Cynthia Putri, Andree Kurniawan
162 [GO] 2021―Aug―28 The effect of the COVID-19 pandemic on telemedicine in pediatric diabetes centers in Italy: results from a longitudinal survey Gianluca Tornese, Riccardo Schiaffini, Enza Mozzillo, Roberto Franceschi, Anna Paola Frongia, Andrea Scaramuzza
163 [GO] 2021―Aug―24 Short-term safety profile of Sars-Cov2 vaccination on glucose control: continuous glucose monitoring data in people with autoimmune diabetes Luca D'Onofrio, Lucia Coraggio, Annalisa Zurru, Angela Carlone, Carmen Mignogna, Chiara Moretti, et al. (+2)
164 [GO] 2021―Aug―13 Effects of the COVID-19 lockdown on primary health care for persons with type 2 diabetes - results from the German Disease Analyzer database Bernd Kowall, Karel Kostev, Rüdiger Landgraf, Hans Hauner, Ralf Bierwirth, Wolfgang Rathmann
165 [GO] 2021―Jul―28 Has COVID-19 lockdown improved glycaemic control in pediatric patients with type 1 diabetes? An analysis of continuous glucose monitoring metrics Lombardo Fortunato, Salzano Giuseppina, Bombaci Bruno, Basile Pietro, Lucania Giovanni, Alibrandi Angela, Passanisi Stefano
166 [GO] 2021―Jul―22 The effect of metformin on mortality and severity in COVID-19 patients with diabetes mellitus Wenxing Yang, Xuehong Sun, Jun Zhang, Kui Zhang
167 [GO] 2021―Jul―21 Diabetes mellitus as a risk factor for SARS-CoV-2 test positivity in Mexico: A propensity score matched study Jacqueline A. Seiglie, Edson Serván-Mori, Jennifer Manne-Goehler, James B. Meigs, J. Jaime Miranda, Sandra G. Sosa-Rubí, et al. (+3)
168 [GO] 2021―Jul―14 Higher admission activated partial thromboplastin time, neutrophil-lymphocyte ratio, serum sodium, and anticoagulant use predict in-hospital COVID-19 mortality in people with Diabetes: Findings from Two University Hospitals in the U.K Ahmed Iqbal, Marni Greig, Muhammad Fahad Arshad, Thomas H. Julian, Sher Ee Tan, Jackie Elliott
169 [GO] 2021―Jul―01 Is diabetes mellitus a wrongdoer to COVID-19 severity? Sanjib Sarkar, Dibyendu Das, Sawlang Borsingh Wann, Jatin Kalita, Prasenjit Manna
170 [GO] 2021―Jun―21 Risk factors for COVID-19 hospitalisation and death in people living with diabetes: a virtual cohort study from the Western Cape Province, South Africa Joel A. Dave, Tsaone Tamuhla, Nicki Tiffin, Naomi S. Levitt, Ian L. Ross, William Toet, et al. (+4)
171 [GO] 2021―Jun―13 Laparoscopic bariatric surgery is safe during phase 2-3 of covid-19 pandemic in italy: a multicenter, prospective, observational study Gianfranco Silecchia, Cristian E. Boru, Giuseppe Maria Marinari, Paolo Gentileschi, Mario Morino, Stefano Olmi, et al. (+5)
172 [GO] 2021―Jun―10 Corrigendum to ‘Perceived risk, behavior changes and Health-related outcomes during COVID-19 pandemic: Findings among adults with and without diabetes in China’. [Diabetes Res. Clin. Practice 167 (2020) 108350] Alice F. Yan, Xiaomin Sun, Jinge Zheng, Baibing Mi, Hui Zuo, Guorui Ruan, et al. (+3)
173 [GO] 2021―Apr―30 Impact of COVID-19 pandemic on glycemic control among outpatients with type 2 diabetes in Japan: A hospital-based survey from a country without lockdown Yasuhiro Tanji, Shojiro Sawada, Taichi Watanabe, Takashi Mita, Yasutaka Kobayashi, Takahisa Murakami, et al. (+2)
174 [GO] 2021―Apr―16 Antibiotic Resistance In Diabetic Foot Infection: How It Changed With COVID-19 Pandemic In A Tertiary Care Center Paola Caruso, Maria Ida Maiorino, Margherita Macera, Giuseppe Signoriello, Laura Castellano, Lorenzo Scappaticcio, et al. (+6)
175 [GO] 2021―Apr―05 Heart failure outcomes and Covid-19 Eberhard Standl, Oliver Schnell
176 [GO] 2021―Mar―18 Unexpectedly lower mortality rates in COVID-19 patients with and without type 2 diabetes in Istanbul Ilhan Satman, Ibrahim Demirci, Cem Haymana, Ilker Tasci, Serpil Salman, Naim Ata, et al. (+13)
177 [GO] 2021―Mar―18 Impact of COVID-19 lockdown on glucose control of elderly people with type 2 diabetes in Italy Pierpaolo Falcetta, Michele Aragona, Annamaria Ciccarone, Alessandra Bertolotto, Fabrizio Campi, Alberto Coppelli, et al. (+4)
178 [GO] 2021―Mar―05 Diabetes, SARS-CoV-2/COVID-19 vaccines and glycemic control: call for data Antonio Ceriello
179 [GO] 2021―Feb―10 Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: results from the CORONADO study Bertrand Cariou, Matthieu Pichelin, Thomas Goronflot, Céline Gonfroy, Michel Marre, Christelle Raffaitin-Cardin, et al. (+4)
180 [GO] 2021―Feb―09 First televisits provided by the Public Health System for patients affected by diabetes mellitus in COVID-19 pandemic Basilio Pintaudi, Giulia Garavaglia, Olga Disoteo, Elena Meneghini, Oscar Massimiliano Epis, Fabrizio Colombo, Federico Bertuzzi
181 [GO] 2021―Feb―03 The Impact of a Prolonged Lockdown and Use of Telemedicine on Glycemic Control in People with Type 1 Diabetes During the COVID-19 Outbreak in Saudi Arabia Sahar K. Alharthi, Ebtihal Y. Alyusuf, Abdullah M. Alguwaihes, Assim Alfadda, Mohammed E. Al-Sofiani
182 [GO] 2021―Jan―30 Why access to diabetes care must not be another victim of the COVID-19 pandemic Andrew Boulton
183 [GO] 2021―Jan―23 The DAR 2020 Global survey : Ramadan fasting during COVID 19 pandemic and the impact of older age on fasting among adults with Type 2 diabetes Mohamed Hassanein, Zanariah Hussein, Inass Shaltout, Wan Juani Wan Seman, Tong Chin Voon, Nurain Mohd Noor, et al. (+13)
184 [GO] 2021―Jan―14 COVID-19 pandemic: Can fasting plasma glucose and HbA1c replace the oral glucose tolerance test to screen for hyperglycaemia in pregnancy? Charlotte Nachtergaele, Eric Vicaut, Sara Pinto, Sopio Tatulashvili, Hélène Bihan, Meriem Sal, et al. (+5)
185 [GO] 2020―Dec―17 Widespread sensory neuropathy in diabetic patients hospitalized with severe COVID-19 infection Ariel Odriozola, Lucía Ortega, Lidia Martinez, Samantha Odriozola, Ainhoa Torrens, David Corroleu, et al. (+7)
186 [GO] 2020―Dec―13 Ramadan fasting in people with type 1 diabetes during COVID-19 pandemic: The DaR Global survey Mohamed Hassanein, Reem M. Alamoudi, Majd-Aldeen Kallash, Naji J. Aljohani, Eman M. Alfadhli, Lobna El Tony, et al. (+11)
187 [GO] 2020―Dec―10 Association of metformin with mortality or ARDS in patients with COVID-19 and type 2 diabetes: a retrospective cohort study Nan Jiang, Zhenyuan Chen, Xiaoxv Yin, Li Liu, Heping Yang, Xiangping Tan, et al. (+6)
188 [GO] 2020―Dec―10 Management of patients with diabetes and obesity in the COVID-19 era: experiences and learnings from South and East Europe, the Middle East, and Africa Francesco Giorgino, Sindeep Bhana, Leszek Czupryniak, Selcuk Dagdelen, Gagik R. Galstyan, Andrej Janež, et al. (+5)
189 [GO] 2020―Dec―09 COVID-19 Associated with Diabetes and Other Noncommunicable Diseases Led to a Global Health Crisis Mark Thomaz Ugliara Barone, Belinda Ngongo, Simone Bega Harnik, Lucas Xavier de Oliveira, Dániel Végh, Patrícia Vieira de Luca, et al. (+5)
190 [GO] 2020―Dec―09 High admission blood glucose independently predicts poor prognosis in COVID-19 patients: A systematic review and dose-response meta-analysis Gilbert Lazarus, Jessica Audrey, Vincent Kharisma Wangsaputra, Alice Tamara, Dicky L. Tahapary
191 [GO] 2020―Dec―03 People living with Type 1 diabetes point of view in COVID-19 times (COVIDT1 Study): disease impact, health system pitfalls and lessons for the future Cristina Tejera, Óscar Moreno-Pérez, Jose Rios, Rebeca Reyes-García
192 [GO] 2020―Nov―22 Risk factors associated with the progression of COVID-19 in elderly diabetes patients Pei Zhang, Maomao Wang, Yang Wang, Yifei Wang, Ting Li, Jing Zeng, et al. (+3)
193 [GO] 2020―Nov―16 COVID-19: No one must be left behind Liliana Tieri
194 [GO] 2020―Nov―13 Prevalence of Diabetes, Management and Outcomes among Covid-19 Adult Patients Admitted in a Specialized Tertiary Hospital in Riyadh, Saudi Arabia Eman Sheshah, Shaun Sabico, Rashed M. Albakr, Anmar A. Sultan, Khalaf S. Alghamdi, Khaled Al Madani, et al. (+2)
195 [GO] 2020―Nov―03 Diabetic retinopathy is independently associated with increased risk of intubation: a single centre cohort study of patients with diabetes hospitalised with COVID-19 Antonella Corcillo, Siew Cohen, Adrian Li, James Crane, Dulmini Kariyawasam, Janaka Karalliedde
196 [GO] 2020―Oct―21 Normal weight obesity and COVID-19 severity: A poorly recognized link Thirunavukkarasu Sathish, Nitin Kapoor
197 [GO] 2020―Oct―21 Impact of obesity, fasting plasma glucose level, blood pressure, and renal function on the severity of COVID-19: a matter of sexual dimorphism? Kyungmin Huh, Rugyeom Lee, Wonjun Ji, Minsun Kang, In Cheol Hwang, Dae Ho Lee, Jaehun Jung
198 [GO] 2020―Oct―16 Effects of work status changes and perceived stress on glycaemic control in individuals with type 1 diabetes during COVID-19 lockdown in Italy Ilaria Barchetta, Flavia Agata Cimini, Laura Bertoccini, Valentina Ceccarelli, Michele Spaccarotella, Marco Giorgio Baroni, Maria Gisella Cavallo
199 [GO] 2020―Oct―15 Factors contributing to glycemic control in diabetes mellitus patients complying with home quarantine during the coronavirus disease 2019 (COVID-19) epidemic Jing Tao, Lianlian Gao, Qinghua Liu, Kun Dong, Jiaojiao Huang, Xuemin Peng, et al. (+3)
200 [GO] 2020―Oct―02 Lessons from COVID-19: how human behaviour may influence the science Antonio Ceriello
202 [GO] 2020―Sep―29 Diabetes and technology: a pilot study on the management of patients with insulin pumps during the COVID-19 pandemic Fabio Petrelli, Giovanni Cangelosi, Stefania Scuri, Paola Pantanetti, Francesca Lavorgna, Federica Faldetta, et al. (+9)
203 [GO] 2020―Sep―25 Type 1 diabetes and COVID-19: the “Lockdown effect” Michele Aragona, Cosimo Rodia, Alessandra Bertolotto, Fabrizio Campi, Alberto Coppelli, Rosa Giannarelli, et al. (+3)
204 [GO] 2020―Sep―24 Clinical characteristics and outcome of hospitalized COVID-19 patients with diabetes: A single-center, retrospective study in Iran Mostafa Akbariqomi, Mahboobeh Sadat Hosseini, Jamal Rashidiani, Hamid Sedighian, Hossein Biganeh, Reza Heidari, et al. (+3)
206 [GO] 2020―Sep―21 Characteristics of patients with diabetes hospitalised for COVID-19 infection-a brief case series report J. Conway, A. Gould, R. Westley, S. Raju, A. Oklopcic, A. Broadbent, et al. (+2)
207 [GO] 2020―Sep―21 Clinical features of patients with type 2 diabetes with and without Covid-19: a case control study (CoViDiab I) Ernesto Maddaloni, Luca D'Onofrio, Francesco Alessandri, Carmen Mignogna, Gaetano Leto, Lucia Coraggio, et al. (+10)
208 [GO] 2020―Sep―17 Hyperglycemia, glucocorticoid therapy, and outcome of COVID-19 Mario Luca Morieri, Gian Paolo Fadini, Federico Boscari, Paola Fioretto, Alberto Maran, Luca Busetto, et al. (+18)
209 [GO] 2020―Sep―16 Use of DPP4 inhibitors in Italy does not correlate with diabetes prevalence among COVID-19 deaths Rocky Strollo, Ernesto Maddaloni, Marco Dauriz, Claudio Pedone, Raffaella Buzzetti, Paolo Pozzilli
210 [GO] 2020―Sep―16 The associations between fasting plasma glucose levels and mortality of COVID-19 in patients without diabetes Yun Huang, Heming Guo, Yan Zhou, Jingjing Guo, Tiantian Wang, Xuming Zhao, et al. (+4)
211 [GO] 2020―Sep―12 Glycemic Control In People With Type 1 Diabetes Using a Hybrid Closed Loop System and Followed by Telemedicine During the COVID-19 Pandemic In Italy Miriam Longo, Paola Caruso, Michela Petrizzo, Filomena Castaldo, Annalisa Sarnataro, Maurizio Gicchino, et al. (+3)
212 [GO] 2020―Sep―12 Inpatient use of glucocorticoids may mediate the detrimental effect of new-onset hyperglycemia on COVID-19 severity Gerui Li
213 [GO] 2020―Sep―10 Fasting blood glucose level is a predictor of mortality in patients with COVID-19 independent of diabetes history Yuli Cai, Shaobo Shi, Fan Yang, Bo Yi, Xiaolin Chen, Junfeng Li, Zhongyuan Wen
214 [GO] 2020―Sep―03 Managing gestational diabetes mellitus using a smartphone application with artificial intelligence (SineDie) during the COVID-19 pandemic: Much more than just telemedicine Lara Albert, Ismael Capel, Gema García-Sáez, Pablo Martín-Redondo, M. Elena Hernando, Mercedes Rigla
215 [GO] 2020―Aug―29 The COVID-19 Pandemic substantially complicates the usual challenges for patients with diabetes in Latin America Arredondo Armando
216 [GO] 2020―Aug―29 Retinal findings in COVID-19 patients with diabetes mellitus Noemi Guemes-Villahoz, Barbara Burgos-Blasco, Juan Donate López, Julián García-Feijoó
217 [GO] 2020―Aug―25 Hyperglycemia without Diabetes and New-Onset Diabetes are both associated with Poorer Outcomes in COVID-19 Awadhesh Kumar Singh, Ritu Singh
218 [GO] 2020―Aug―25 Caring for a Child with Type 1 Diabetes During COVID-19 lockdown in a developing country: Challenges and Parents’ Perspectives on the Use of Telemedicine Rasha Odeh, Lobna Gharaibeh, Amirah Daher, Sara Kussad, Abeer Alassaf
219 [GO] 2020―Aug―25 “Diabetes as a case study of chronic disease management”: eight years later. The opportunity learned from the COVID-19 pandemic Antonio Ceriello
220 [GO] 2020―Aug―25 Diabetic ketoacidosis during COVID-19 pandemic in a developing country Marcio José Concepción Zavaleta, Cristian David Armas Flórez, Esteban Alberto Plasencia Dueñas, Julia Cristina Coronado Arroyo
221 [GO] 2020―Aug―25 The association of diabetes and the prognosis of COVID-19 patients: a retrospective study Zhelong Liu, Xi Bai, Xia Han, Wangyan Jiang, Lin Qiu, Shi Chen, Xuefeng Yu
222 [GO] 2020―Aug―25 J-shaped Association Between Fasting Blood Glucose Levels and COVID-19 Severity in Patients without Diabetes Bing Zhu, Shengwei Jin, Lianpeng Wu, Chenchan Hu, Zhen Wang, Le Bu, et al. (+4)
223 [GO] 2020―Aug―25 The challenge of diabetes home control in COVID-19 times: proof is in the pudding Laura Cotovad-Bellas, Cristina Tejera-Pérez, Alma Prieto-Tenreiro, Ana Sánchez-Bao, Diego Bellido-Guerrero
224 [GO] 2020―Aug―25 Hyperglycemia and COVID-19: what was known and what is really new? Antonio Ceriello
225 [GO] 2020―Aug―20 Caring for children and adolescents with type 1 diabetes mellitus: italian society for pediatric and adolescent diabetes (ISPED) Statements during COVID-19 pandemia Giuseppe d'Annunzio, Claudio Maffeis, Valentino Cherubini, Ivana Rabbone, Andrea Scaramuzza, Riccardo Schiaffini, et al. (+3)
226 [GO] 2020―Aug―15 Newly-diagnosed diabetes and admission hyperglycemia predict COVID-19 severity by aggravating respiratory deterioration Gian Paolo Fadini, Mario Luca Morieri, Federico Boscari, Paola Fioretto, Alberto Maran, Luca Busetto, et al. (+16)
227 [GO] 2020―Jul―30 Why diabetes must not be forgotten in the global fight against COVID-19 Andrew Boulton
228 [GO] 2020―Jul―30 The impact of strict COVID-19 lockdown in Spain on glycemic profiles in patients with type 1 Diabetes prone to hypoglycemia using standalone continuous glucose monitoring Alex Mesa, Clara Viñals, Irene Pueyo, Daria Roca, Mercè Vidal, Marga Giménez, Ignacio Conget
229 [GO] 2020―Jul―30 Testing for gestational diabetes during the COVID-19 pandemic. An evaluation of proposed protocols for the United Kingdom, Canada and Australia H David McIntyre, Kristen S Gibbons, Ronald C W Ma, Wing Hung Tam, David A Sacks, Julia Lowe, et al. (+2)
230 [GO] 2020―Jul―27 Is blood glucose or obesity responsible for the bad prognosis of COVID-19 in obesity -diabetes? Antonio E. Pontiroli, Lucia La Sala, Davide Chiumello, Franco Folli
231 [GO] 2020―Jul―24 Hyperglycemia is a strong predictor of poor prognosis in COVID-19 Sheng-ping Liu, Qin Zhang, Wei Wang, Min Zhang, Chun Liu, Xuefei Xiao, et al. (+3)
232 [GO] 2020―Jul―23 Delineating clinical characteristics and comorbidities among 206 COVID-19deceasedpatients in India: Emerging significance of renin angiotensin system derangement Jaseela Majeed, Puneeta Ajmera, Ramesh K .Goyal
233 [GO] 2020―Jul―22 Analysis of the lymphocyte count in type 2 diabetic patients with coronavirus disease (COVID-19): A retrospective study in a centralized treatment center Dingye Wu, Song Gao
234 [GO] 2020―Jul―22 Knowledge, attitudes and practices towards COVID-19 among young adults with Type 1 Diabetes Mellitus amid the nationwide lockdown in India: A cross-sectional survey Rimesh Pal, Urmila Yadav, Sandeep Grover, Banshi Saboo, Anmol Verma, Sanjay K. Bhadada
235 [GO] 2020―Jul―22 Lymphocyte subsets with the lowest decline at baselineand the slow lowest rise during recovery in COVID-19 critical illnesspatients with diabetes mellitus Dafeng Liu, Lijuan Lan, Dongxia Luo, Bennan Zhao, Guo Wei, Yinsheng He, et al. (+2)
236 [GO] 2020―Jul―22 Impact of covid-19 lockdown on glycemic control in patients with type 1 diabetes Elsa Fernández, Alicia Cortazar, Virginia Bellido
237 [GO] 2020―Jul―22 Recommendations and management of hyperglycaemia in pregnancy during COVID-19 pandemic in Italy Elisabetta Torlone, Maria Angela Sculli, Matteo Bonomo, Antonino Di Benedetto, Graziano Di Cianni, Camilla Festa, et al. (+8)
238 [GO] 2020―Jul―22 Perceived Risk, Behavior Changes and Health-related Outcomes During COVID-19 Pandemic: Findings among Adults with and without Diabetes in China Alice F. Yan, Xiaomin Sun, Jinge Zheng, Baibing Mi, Hui Zuo, Guorui Ruan, et al. (+3)
239 [GO] 2020―Jul―22 Comorbid diabetes and the risk of disease severity or death among 8807 COVID-19 patients in China: a meta-analysis Li Guo, Zumin Shi, Ya Zhang, Cuicui Wang, Nayla Cristina Do Vale Moreira, Hui Zuo, Akhtar Hussain
240 [GO] 2020―Jul―22 Characteristics of laboratory findings of COVID-19 patients with comorbid diabetes mellitus Jing Jing Liang, Jun Liu, Yong Chen, Bo Ye, Na Li, Xiao Wang, et al. (+2)
241 [GO] 2020―Jul―22 Diabetes and COVID-19: A systematic review on the current evidences Alireza Abdi, Milad Jalilian, Pegah Ahmadi Sarbarzeh, Zeljko Vlaisavljevic
242 [GO] 2020―Jul―22 The COVID19 Pandemic - Perspectives from People Living with Diabetes Rose Kyle Jacques, Scibilia Renza
243 [GO] 2020―Jul―21 COVID-19 and Diabetes: International Diabetes Federation Perspectives Akhtar Hussain, Andrew JM Boulton
244 [GO] 2020―Jul―18 Diabetes and CoViD-19: experience from the frontline of Internal Medicine wards in Italy Montagnani A, Pieralli F, Gnerre P, Pomero F, Campanini M, Dentali F, et al. (+2)
245 [GO] 2020―Jul―17 Demographic and Clinical Features of Critically Ill Patients with COVID-19 in Greece: The Burden of Diabetes and Obesity P. Halvatsiotis, A. Kotanidou, K. Tzannis, E. Jahaj, E. Magira, M. Theodorakopoulou, et al. (+18)
246 [GO] 2020―Jul―14 Diabetes care during COVID-19 lockdown at a tertiary care centre in India Rajnish Joshi, Shubham Atal, Zeenat Fatima, Sadasivam Balakrishnan, Swati Sharma, Ankur Joshi
247 [GO] 2020―Jul―12 A case presentation for positive SARS-CoV-2 RNA recurrence in a patient with a history of type 2 diabetes that had recovered from severe COVID-19 Chengyun Dou, Xia Xie, Zhongtian Peng, Haibo Tang, Zheng Jiang, Zhefeng Zhong, Jian Tang
248 [GO] 2020―Jul―12 Comment on “Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus” Yutong Wu, Yite Xu, Zhaoyou Meng
249 [GO] 2020―Jul―08 Coronavirus lockdown effect on type 1 diabetes management οn children wearing insulin pump equipped with continuous glucose monitoring system Athanasios Christoforidis, Evgenia Kavoura, Aggeliki Nemtsa, Konstantina Pappa, Meropi Dimitriadou
250 [GO] 2020―Jul―03 Coronavirus disease (Covid-19): how does the exercise practice in active people with Type 1 Diabetes change? A preliminary survey Roberta Assaloni, Vittoria Carnevale Pellino, Mariangela V. Puci, Ottavia E. Ferraro, Nicola Lovecchio, Angela Girelli, Matteo Vandoni
251 [GO] 2020―Jul―03 COVID-19 Impact on People with Diabetes in the South and Central America Mark Thomaz Ugliara Barone, Douglas Villarroel, Patrícia Vieira de Luca, Simone Bega Harnik, Bruna Lima, Ronaldo José Pineda Wieselberg, Viviana Giampaoli
252 [GO] 2020―Jul―03 Reply to comments on Letter to the Editor - Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus Ying Jie Chee, Shereen Jia Huey Ng, Ester Yeoh
253 [GO] 2020―Jul―03 The Impact of COVID-19 on People with Diabetes in Brazil Mark Thomaz Ugliara Barone, Simone Bega Harnik, Patrícia Vieira de Luca, Bruna Letícia de Souza Lima, Ronaldo José Pineda Wieselberg, Belinda Ngongo, et al. (+6)
254 [GO] 2020―Jul―03 Considerations for people with diabetes during the Coronavirus Disease (COVID-19) Pandemic Lori J Sacks, Cecilia Pham, Nicola Fleming, Sandra L. Neoh, Elif I Ekinci
255 [GO] 2020―Jul―03 Sustainable Diabetes Care Services during COVID-19 Pandemic Dalal Alromaihi, Naji Alamuddin, Suby George
256 [GO] 2020―Jul―03 Risk Factors for Mortality among COVID-19 Patients Orwa Albitar, Rama Ballouze, Jer Ping Ooi, Siti Maisharah Sheikh Ghadzi
257 [GO] 2020―Jul―03 Baseline characteristics and risk factors for short-term outcomes in 132 COVID-19 patients with diabetes in Wuhan China: a retrospective study Yumin Li, Xiaoyu Han, Osamah Alwalid, Yue Cui, Yukun Cao, Jia Liu, et al. (+4)
258 [GO] 2020―Jul―03 Association of diabetes and hypertension with disease severity in covid-19 patients: a systematic literature review and exploratory meta-analysis Rizwana Parveen, Nouroz Sehar, Ram Bajpai, Nidhi Bharal Agarwal
259 [GO] 2020―Jul―03 School and pre-school children with type 1 diabetes during covid-19 quarantine: the synergic effect of parental care and technology Riccardo Schiaffini, Fabrizio Barbetti, Novella Rapini, Elena Inzaghi, Annalisa Deodati, Ippolita P Patera, et al. (+6)
260 [GO] 2020―Jul―03 Diabetes and COVID-19: Global and Regional Perspectives In-Kyung Jeong, Kun Ho Yoon, Moon Kyu Lee
261 [GO] 2020―Jul―03 A Novel Indicator Predicts 2019 Novel Coronavirus Infection in Subjects with Diabetes Aclan Ozder
262 [GO] 2020―Jul―03 Letter to the Editor in response to the article “Lack of type 1 diabetes involvement in the SARS-CoV-2 population: Only a particular coincidence? Stephen Charles Bronson
263 [GO] 2020―Jun―29 High prevalence of COVID-19-associated diabetic ketoacidosis in UK secondary care Nina Goldman, Douglas Fink, James Cai, Yun-Ni Lee, Zoe Davies
264 [GO] 2020―Jun―25 A proposed mechanism for the possible therapeutic potential of Metformin in COVID-19 Zohreh Esam
265 [GO] 2020―Jun―25 COVID-19 and Diabetes from IDF MENA Region JJamal BELKHADIR
266 [GO] 2020―Jun―25 H(ome)bA1c Testing and Telemedicine: High Satisfaction of People with Diabetes for Diabetes Management During COVID-19 Lockdown Karin Kanc, Jana Komel, Miha Kos, Julie Wagner
267 [GO] 2020―Jun―25 Clinical Characteristics and Outcome in Patients with Combined Diabetic Ketoacidosis and Hyperosmolar Hyperglycemic State Associated with COVID-19: A Retrospective, Hospital-Based Observational Case Series Kok Hoe Chan, Divya Thimmareddygari, Amr Ramahi, Liana Atallah, Nicholas G. Baranetsky, Jihad Slim
268 [GO] 2020―Jun―25 Well-controlled vs Poorly-controlled Diabetes in Patients with COVID-19: Are There Any Differences in Outcomes and Imaging Findings? Masoomeh Raoufi, Shayesteh Khalili, Mohsen Mansouri, Ali Mahdavi, Neda Khalili
269 [GO] 2020―Jun―25 Diabetes and COVID-19: IDF perspective in the Western Pacific Region Yerin Hwang, Altaisaikhan Khasag, Weiping Jia, Alicia Jenkins, Chien-Ning Huang, Daisuke Yabe, et al. (+3)
270 [GO] 2020―Jun―25 Retinal outcomes of COVID-19: possible role of CD147 and cytokine storm in infected patients with diabetes mellitus Ícaro Raony, Camila Saggioro de Figueiredo
271 [GO] 2020―Jun―24 COVID-19 and Type 1 Diabetes: Challenges and actions Emma L. Klatman, Stephane Besancon, Silver Bahendeka, Mary Mayige, Graham D. Ogle
272 [GO] 2020―Jun―13 Letter to the Editor: CoVid-19 and Type 1 Diabetes: every cloud has a silver lining. Searching the reason of a lower aggressiveness of the CoronaVirus disease in Type 1 Diabetes A Zanfardino
273 [GO] 2020―Jun―11 Assessment of risk, severity, mortality, glycemic control and antidiabetic agents in patients with diabetes and COVID-19: A Narrative Review Awadhesh Kumar Singh, Kamlesh Khunti
274 [GO] 2020―Jun―11 Is Metformin ahead in the race as a repurposed host-directed therapy for patients with diabetes and COVID-19? Awadhesh Kumar Singh, Ritu Singh
275 [GO] 2020―Jun―10 Clinical characteristics and outcomes of COVID-19 hospitalized patients with diabetes in UK: A retrospective single centre study Alamin Alkundi, Ibrahim Mahmoud, Abdulmajid Musa, Saima Naveed, Mohammed Alshawaf
276 [GO] 2020―Jun―02 The Australian response to the COVID-19 pandemic and diabetes - lessons learned Sof Andrikopoulos, Greg Johnson
277 [GO] 2020―Jun―01 Management of diabetic persons with foot ulceration during COVID-19 health care emergency: effectiveness of a new triage pathway Meloni Marco, Izzo Valentina, Giurato Laura, Gandini Roberto, Uccioli Luigi
278 [GO] 2020―May―30 Breastfeeding during the COVID-19 pandemic: suggestions on behalf of Woman Study Group of AMD C. Giuliani, P. Li Volsi, E. Brun, A. Chiambretti, A. Giandalia, L. Tonutti, et al. (+2)
279 [GO] 2020―May―30 COVID-19: Perspectives from people with diabetes
280 [GO] 2020―May―22 Metformin, Neutrophils and COVID-19 Infection Rinkoo Dalan
281 [GO] 2020―May―22 Characteristics and Outcomes of COVID-19 Positive Patients with Diabetes Managed as Outpatients Julie M. Shabto, Leah Loerinc, Ghazala A. O'Keefe, James O'Keefe
282 [GO] 2020―May―22 Association of Diabetes Mellitus with Disease Severity and Prognosis in COVID-19: A Retrospective Cohort Study Yan Zhang, Yanhui Cui, Minxue Shen, Jianchu Zhang, Ben Liu, Minhui Dai, et al. (+9)
283 [GO] 2020―May―22 SARS-CoV-2 and Diabetes: New Challenges for the Disease Cecília Cristelo, Cláudia Azevedo, Joana Moreira Marques, Rute Nunes, Bruno Sarmento
284 [GO] 2020―May―20 TYPE 1 DIABETES TRIGGERED BY COVID-19 PANDEMIC: A POTENTIAL OUTBREAK? Paola Caruso, Miriam Longo, Katherine Esposito, Maria Ida Maiorino
285 [GO] 2020―May―19 Nexus of COVID-19 and diabetes pandemics: Global public health lessons Michael Bergman, Ram Jagannathan, K.M. Venkat Narayan
286 [GO] 2020―May―19 Is DPP4 inhibition a comrade or adversary in COVID-19 infection Rinkoo Dalan
287 [GO] 2020―May―19 Lack of type 1 diabetes involvement in SARS-COV-2 population: Only a particular coincidence? Dario Pitocco, Linda Tartaglione, Luca Viti, Mauro Di Leo, Andrea Manto, Salvatore Caputo, Alfredo Pontecorvi
288 [GO] 2020―May―18 Glycosylated hemoglobin is associated with systemic inflammation, hypercoagulability, and prognosis of COVID-19 patients Zhenzhou Wang, Zhe Du, Fengxue Zhu
289 [GO] 2020―May―13 The contribution of diabetic micro-angiopathy to adverse outcomes in COVID-19 Martin B. Whyte, Prashanth Vas, Christian Heiss, Michael D. Feher
290 [GO] 2020―May―12 Prevalence of diabetes mellitus in 2019 novel coronavirus: a Meta-analysis Xiang Wang, Shoujun Wang, Liangge Sun, Guijun Qin
291 [GO] 2020―May―12 Parallel epidemics, or nearly so: certainties and uncertainties about sars-cov-2 in italy Sandro Gentile, Andrea Mambro, Felice Strollo
292 [GO] 2020―May―06 Reply to comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?” Rimesh Pal, Sanjay K. Bhadada
293 [GO] 2020―May―06 Timely glucose monitoring-related potential risk of occupational exposure during the pandemic of COVID-19: A diabetologist's perspective Xiaowei Wei, Weibo Zhao, Aihong Wang, Zhangrong Xu
294 [GO] 2020―May―01 Admission Hyperglycemia and Radiological findings of SARS-COv2 in patients with and without Diabetes Gianluca Iacobellis, Carlos A. Penaherrera, Luis E. Bermudez, Ernesto Bernal Mizrachi
295 [GO] 2020―Apr―30 Comment on “Should anti-diabetic medications be reconsidered amid COVID-19 pandemic?” Erkan Cure, Medine Cumhur Cure
296 [GO] 2020―Apr―30 Metformin in COVID-19: A Possible Role Beyond Diabetes Swati Sharma, Avik Ray, Balakrishnan Sadasivam
297 [GO] 2020―Apr―29 Hyperglycemia and the worse prognosis of COVID-19. Why a fast blood glucose control should be mandatory Antonio Ceriello
298 [GO] 2020―Apr―24 COVID-19 and diabetes: is metformin a friend or foe? Francesco Ursini, Jacopo Ciaffi, Maria Paola Landini, Riccardo Meliconi
299 [GO] 2020―Apr―24 Diabetic ketoacidosis precipitated by Covid-19 in a patient with newly diagnosed diabetes mellitus Ying Jie Chee, Shereen Jia Huey Ng, Ester Yeoh
300 [GO] 2020―Apr―23 COVID-19 and diabetes: Is this association driven by the DPP4 receptor? Potential clinical and therapeutic implications Ilaria Barchetta, Maria Gisella Cavallo, Marco Giorgio Baroni
301 [GO] 2020―Apr―23 SARS-CoV-2 and DPP4 inhibition: is it time to pray for Janus Bifrons? Dario Pitocco, Linda Tartaglione, Luca Viti, Mauro Di Leo, Alfredo Pontecorvi, Salvatore Caputo
302 [GO] 2020―Apr―17 COVID-19 and diabetes management: What should be considered? Antonio Ceriello, Anca Pantea Stoian, Manfredi Rizzo
303 [GO] 2020―Apr―10 Should anti-diabetic medications be reconsidered amid COVID-19 pandemic? Rimesh Pal, Sanjay K Bhadada
304 [GO] 2020―Apr―09 COVID-19 and diabetes: Knowledge in progress Akhtar Hussain, Bishwajit Bhowmik, Nayla Cristina do Vale Moreira
305 [GO] 2020―Apr―06 Commentary: COVID-19 and diabetes Carmen V. Villabona
306 [GO] 2020―Apr―04 COVID-19 Infection in italian people with diabetes: lessons learned for our future (an experience to be used) Sandro Gentile, Felice Strollo, Antonio Ceriello
307 [GO] 2020―Mar―29 COVID-19, Diabetes Mellitus and ACE2: The conundrum Rimesh Pal, Anil Bhansali
308 [GO] 2020―Mar―27 COVID-19 and Diabetes: can DPP4 inhibition play a role? Gianluca Iacobellis
309 [GO] 2020―Mar―13 Timely blood glucose management for the outbreak of 2019 novel coronavirus disease (COVID-19) is urgently needed Aihong Wang, Weibo Zhao, Zhangrong Xu, Jianwen Gu

309 Results       Page 1


Last change 2023―Oct―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.023 sec